MCSC named after a.s. Loginov will take part in a clinical trial in the field of hematology
NewsOn the basis of the Moscow Clinical Research Center named after A.S. Loginov, two clinical studies in the field of hematology will be conducted with the aim of import substitution of a foreign drug.
"We have created an ecosystem for conducting clinical trials of medicines and are rapidly implementing the Moscow Mayor's program to strengthen measures to support manufacturing companies conducting clinical trials in order to develop and register vital and innovative medicines," said Anastasia Rakova, Deputy Mayor of Moscow for Social Development.
The Moscow government has allocated funds to conduct research on a drug aimed at treating chronic idiopathic thrombocytopenic purpura, an autoimmune hematological disease associated with increased destruction of blood elements of platelets involved in its coagulation processes.
#Переведено YandexTranslate
